Olverembatinib Treatment in Pediatric Patients With Relapsed Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Olverembatinib Treatment in Pediatric Patients With Relapsed Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia

Published:2023-09 Issue:9 Volume:23 Page:660-666
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Li Xiaolan,Zhang Jingliao,Liu Fang,Liu Tianfeng,Zhang Ranran,Chen Yumei,Guo Ye,Fang Yongjun,Xu Xiaojun,Pui Ching-Hon^ORCID,Zhu Xiaofan

Funder

Ministry of Science and Technology of the People's Republic of China

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

St Jude Children's Research Hospital

American Lebanese Syrian Associated Charities

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference17 articles.

1. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005;Arico;J Clin Oncol,2010

2. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study;Schultz;J Clin Oncol,2009

3. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: children's Oncology Group study AALL0031;Schultz;Leukemia,2014

4. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study;Biondi;Lancet Oncol,2012

5. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial;Biondi;Lancet Haematol,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2023-11-25

2. Case report: Olverembatinib monotherapy: the chemotherapy-free regimen for an elderly patient with relapsed Ph-positive acute lymphoblastic leukemia;Frontiers in Pharmacology;2023-11-16

3. Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome–positive acute lymphoblastic leukemia: two-case report;Annals of Hematology;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3